Chroma Medicine
Main focus: Epigenetic engineering
Company stage: Pre-clinical
Diseases: Undisclosed
(Epi) Genome-editing tool: Undisclosed
Funding stage: Private
Location: Cambridge, MA, USA
Website: https://chromamedicine.com/
Chroma Medicine is a start-up company focused on engineering the epigenome. The company develops epigenetic editors that are able to either silence or activate genes by targeted methylation and demethylation of DNA. Recently, the company raised $125M in a Series A funding round.